Inför Q1 från Remedy på måndag. Inderes Remedy Q1 on Monday: Our forecast sees AW2 royalties only starting to show in... Remedy will report its Q1 results on Monday at 9.00 am EEST. We will review the report afresh in Remedy earnings live starting at 8.55 am (in Finnish). We still expect a very weak quarter in terms of numbers before AW2 starts to generate royalties in...

Här är analytikern @Atte_Riikola:s kommentarer om de senaste nyheterna från det här intressanta finska spelföretaget. Remedy announced on Thursday a strategic partnership agreement with Annapurna Pictures for Control 2. Remedy will self-publish the game, but Annapurna will fund 50% of the game and have the rights to extend the Control and Alan Wake brands into film and television. In our projections, we had assumed that Remedy would fund Control 2 entirely on its own and raise additional funds to do so. The current agreement is more balanced from a risk perspective and eliminates the need for additional funding that we had anticipated. At the same time, the deal offers good royalty potential and a low-risk opportunity to reach new audiences through movies and TV series. Overall, we view the deal as good for Remedy and will update our forecasts accordingly in the near future. Inderes Remedy finds good strategic partner for Control 2 - Inderes Remedy announced on Thursday a strategic partnership agreement with Annapurna Pictures for Control 2. Remedy will self-publish the game, but Annapurna will fund 50% of the game and have the rights to extend the Control and Alan Wake brands into...

BREAKING NEWS FROM REMEDY!!! Inderes Remedy acquires full rights to the Control franchise from 505 Games at a good... We see the agreement as very positive for Remedy's long-term potential, as the company is now in a strong position to decide to self-publish future Control games and/or to negotiate with a new publishing partner to finance projects on better terms.

Här är en färsk analys av Remedy. Inderes Remedy: AW2 sales figures fell short of our overly optimistic expectations -... Friday's sales figures for Alan Wake 2 show that the game is off to a good start and is Remedy's fastest selling game to date. However, following very positive critical reviews, we expected an even faster start and have now revised our overly... Friday’s sales figures for Alan Wake 2 show that the game is off to a good start and is Remedy’s fastest selling game to date. However, following very positive critical reviews, we expected an even faster start and have now revised our overly optimistic forecasts downwards.

Remedyn aktiekurs har sjunkit mycket, delvis av en anledning, men kanske till och med för mycket. Hur som helst, detta företag har skapat fantastiska spel, som Alan Wake. Jag gillar Inderes analyser eftersom de är ärliga. De är till exempel inte alltför tjuriga. Inderes Remedy: Back in the game - Inderes The investor sentiment around Remedy has recently soured, where we believe the key factors are the write-down of Vanguard’s development expenditure and the postponement of the financial statements based on publishing contract negotiations. In... The investor sentiment around Remedy has recently soured, where we believe the key factors are the write-down of Vanguard’s development expenditure and the postponement of the financial statements based on publishing contract negotiations. In addition, uncertainty about Alan Wake 2’s commercial success causes uncertainty around the stock. We believe that the content of the publishing contract and the sales figures of AW2 will be clarified in connection with the financial statements (3/20) at the latest, and with the decreased valuation we feel Remedy’s long-term potential looks interesting again.

Det här är en analys gjord efter Remedys tredje kvartal som är av hög kvalitet och både lättläst och lätt att förstå på ett omfattande sätt. Inderes Remedy Q3'24: Long-term potential is building - Inderes The company's Q3 results were well above expectations and the game projects in development are progressing well. However, the sales performance of Alan Wake 2 has been disappointing compared to our expectations, and the company now has something to...

Remedys resultat för tredje kvartalet var starkare än väntat, särskilt tack vare utvecklingsavgifterna från Control 2-projektet. Företagets spelprojekt fortskrider enligt planerna, men Alan Wake 2 har ännu inte täckt sina utvecklings- och marknadsföringskostnader. Detta ökar pressen på spelets försäljning under årets sista månader, då förväntningarna är som högst. Omsättningen ökade betydligt mer än väntat, främst tack vare utvecklingsavgifter kopplade till Annapurna-avtalet. Däremot minskade royaltyintäkterna något jämfört med förväntningarna. Företagets fasta kostnadsstruktur stödde ett starkt resultat, men på grund av Control-spelens egenutgivningsstrategi kommer räkenskapsåret fortfarande att sluta på förlust. Nedan följer analytikerns kommentarer om resultatet. Inderes Remedy Q3'24 flash comment: Figures above expectations, but AW2 sales... Remedy reported significantly stronger Q3 figures this morning than we expected, as more development fees from the Control 2 project were recognized in the quarter than we anticipated. The company's game projects are also progressing in line with our...